Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials-Reference-Cited by-同舟云学术

Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials

Published:2019-07-22 Issue:11 Volume:24 Page:1397-1405
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hirose Kosuke,Oki Eiji^ORCID,Shimose Takayuki,Sakamoto Sanae,Sasaki Shun,Jogo Tomoko,Hu Qingjiang,Tsuda Yasuo,Ando Koji,Nakashima Yuichiro,Saeki Hiroshi,Mori Masaki

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01509-8.pdf

Reference38 articles.

1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

2. Heinemann V, Rivera F, O’Neil BH et al (2016) A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer. Eur J Cancer 67:11–20

3. Holch J, Stintzing S, Heinemann V (2016) Treatment of metastatic colorectal cancer: standard of care and future perspectives. Visc Med 32:178–183

4. Gopal S (2016) Moonshot to Malawi. N Engl J Med 374:1604–1605

5. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer;Targeted Oncology;2024-04-30